Skip to main content

Table 1 Demographic, clinical features, motor, and sensory level changes of the patients

From: Combining cell therapy with human autologous Schwann cell and bone marrow-derived mesenchymal stem cell in patients with subacute complete spinal cord injury: safety considerations and possible outcomes

Patient number Sex Age (years) Cause of injury LOI Interval between injection and trauma (months) Motor level pre-treatment Motor level 6 months after treatment Motor level 12 months after treatment Sensory level pre-treatment Sensory level 6 months after treatment Sensory level 12 months after treatment
1 Male 18 Accident C4 3 C7 C7 C8 T4 T4 T4
2 Female 42 Accident T3 7 T1 T1 T1 T3 T4 T4
3 Female 38 Accident T10 3.5 L1 L1 L1 L1 L1 L1
4 Male 27 Accident C5 5 C6 C7 C7 C5 C5 C5
5 Male 21 Accident T12 9 T1 L3 L3 L5 L5 L5
6 Male 30 Accident T6 5.5 T1 T1 T1 T8 T10 T10
7 Male 17 Falling T5 3 T1 T1 T1 T5 T9 T9
8 Male 30 Accident C5 4 C7 C7 C7 T2 T3 T3
9 Male 19 Accident T2 7 T1 T1 - T3 T3 T12
10 Male 40 Accident T11 3 T1 T1 - T12 T12 -
11 Male 38 Accident C5 8 C7 C8 C8 C4 C4 C4
  1. LOI level of injury